“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Study on tumour biology and the aging effect of chemotherapeutic treatment in older breast cancer patients

€2.42

SKU: product-article-10777 Category: General

Description

Description

Study on tumour biology and the aging effect of chemotherapeutic treatment in older breast cancer patients

Top

Article: Study on tumour biology and the aging effect of chemotherapeutic treatment in older breast cancer patients

Description

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in breast cancer